Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets Abpro to receive up to $1.1 billion, including a $30 million upfront equity investment, clinical funding, milestones, and royalties Abpro grants exclusive license to Abpro Bio, formerly named Ugint...